SHARPE
Reported results
- Net sales increased 34% to $244 million for the third quarter ended September 30, 2026, compared to $182 million in the prior year period.
- Non-GAAP organic net sales growth was 18% in the third quarter.
- Gross profit was $93 million, an increase of $24 million compared to $69 million in the prior year period.
- GAAP net income was $35 million, or $0.58 per diluted share, compared to $24 million, or $0.40 per diluted share, in the prior year period.
- Non-GAAP Adjusted EBITDA was $53 million, compared to $32 million in the prior year period.
Guidance
- Full year 2026 net sales expected to be between $810 million and $820 million.
- Full year 2026 gross margin expected to be approximately 40%.
- Fourth quarter 2026 gross margin expected to be approximately 33%.
- Expect to deliver SG&A leverage of approximately 1.5 percentage points of net sales vs. 2025.
- Full year 2026 Non-GAAP Adjusted EBITDA expected to be in the range of $170 million to $175 million.
Notes
Third quarter 2026 financial results benefited from the contribution of Copra, which was acquired in July 2026.
Price and volatility reaction
The stock moved -7.1% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -17.3 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 63.5 | 2026-10-21 |
| Close after release | 59 | 2026-10-22 |
| Realised move | -7.1% | close to close |
| 30d ATM IV change | -17.3 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-22 (8-K, Item 2.02). Read the original filing on sec.gov.